InvestorsHub Logo
Followers 12
Posts 1139
Boards Moderated 0
Alias Born 02/13/2018

Re: None

Thursday, 12/24/2020 9:19:45 PM

Thursday, December 24, 2020 9:19:45 PM

Post# of 232503
Seriously, I don’t know the answer to this but I’m curious how many drugs that are granted open label extensions are denied approval following completion/evaluation of their phase III

This is a way for the FDA to get patients access before formal approval. They know other countries are coming and NP has made it clear...first come first serve. It may be a bluff but it’s a powerful statement that the FDA needs to consider. They can’t slow walk this one
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News